Efficacy and Safety of Two Treatment Regimens of Topical MOB015 in Adults With Distal Subungual Onychomycosis
NCT01246518
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
250
Enrollment
INDUSTRY
Sponsor class
Conditions
Onychomycosis
Interventions
DRUG:
MOB015
Sponsor
Moberg Pharma AB